Data Deep Dive: CAR T-Cell Therapy for Large B-Cell Lymphoma
Summary
Tune into our first episode in the Avalere Health Essential Voice series focused on disease education. In this segment, our experts discuss recent research that, using Medicare fee-for-service claims data, studied healthcare utilization, costs, outcomes, and other characteristics of patients who received CAR T-cell therapy for large B-cell lymphoma.To listen to this video as a podcast or read the transcript, please visit our podcast page.
2025: Opportunity Through Uncertainty
Sign Up for Our 2025 Healthcare Industry Outlook Webinar
Register Now
January 23, 11 AM ET
Learn MoreServices
From beginning to end, our team synergy
produces measurable results. Let's work together.
produces measurable results. Let's work together.